[1]
|
BANCHEREAU J,STEINMAN RM.Dendritic cells and the control of immunity[J].Nature,1998,392(6673):245. |
[2]
|
SWIECKI M,COLONNA M.The multifaceted biology of plasmacytoid dendritic cells[J].Nat Rev Immunol,2015,15(8):471. |
[3]
|
RÖNNBLOM L.The importance of the type I interferon system in autoimmunity[J].Clin Exp Rheumatol,2016,34(4 Suppl 98):21. |
[4]
|
LIU Z,DAVIDSON A.Taming lupus-a new understanding of pathogenesis is leading to clinical advances[J].Nat Med,2012,18(6):871. |
[5]
|
CHRISTENSEN SR,SHUPE J,NICKERSON K,et al.Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus[J].Immunity,2006,25(3):417. |
[6]
|
NICKERSON KM,CHRISTENSEN SR,SHUPE J,et al.TLR9 regulates TLR7-and MyD88-dependent autoantibody production and disease in a murine model of lupus[J].J Immunol,2010,184(4):1840. |
[7]
|
王涛,李志军,李柏青.等.Toll样受体7及9在系统性红斑狼疮患者外周血B淋巴细胞内的表达及意义[J].中华风湿病学杂志,2009,13(8):560. |
[8]
|
ACHEK A,YESUDHAS D.Toll-like receptors:promising therapeutic targets for inflammatory diseases[J].Arch Pharm Res,2016,39(8):1032. |
[9]
|
CLANCY RM,MARKHAM AJ,BUYON JP.Endosomal Toll-like receptors in clinically overt and silent autoimmunity[J].Immunol Rev,2016,269(1):76. |
[10]
|
CELHAR T,FAIRHURST AM.Toll-like receptors in systemic lupus erythematosus:potential for personalized treatment[J].Front Pharmacol,2014,5(5):265. |
[11]
|
FUKUI R,SAITOH S,KANNO A,et al.Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking[J].Immunity,2011,35(1):69. |
[12]
|
YOKOGAWA M,TAKAISHI M,NAKAJIMA K,et al.Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice:a new model of systemic Lupus erythematosus[J].Arthritis Rheumatol,2014,66(3):694. |
[13]
|
CELHAR T,YASUGA H,LEE HY,et al.TLR9 deficiency breaks tolerance to RNA-associated antigens and upregulates TLR7 protein in Sle1 mice[J].Arthritis Rheumatol,2018. |
[14]
|
TAKAGI H,ARIMURA K,UTO T,et al.Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation[J].Scientific Reports,2016,6:24477. |
[15]
|
赵小娟,汪国生,俞大亮,等.系统性红斑狼疮患者外周血树突状细胞的变化及意义[J].安徽医科大学学报,2012,47(8):948. |
[16]
|
WORBS T,HAMMERSCHMIDT SI.Dendritic cell migration in health and disease[J].Nat Rev Immunol,2017,17(1):30. |
[17]
|
JIN O,KAVIKONDALA S,SUN L,et al.Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells,but decreased myeloid dendritic cells with deficient CD83 expression[J].Lupus,2008,17(7):654. |
[18]
|
郭文静,陈琳洁,李志军,等.系统性红斑狼疮患者外周血浆细胞样树突状细胞的变化及意义[J].蚌埠医学院学报,2016,41(8):995. |
[19]
|
MURAYAMA G,FURUSAWA N,CHIBA A,et al.Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus[J].Arthritis Research Therapy,2017,19(1):234. |
[20]
|
LYN-COOK BD,XIE C,OATES J,et al.Increased expression of Toll-like receptors(TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus(SLE) patients:ethnic differences and potential new targets for therapeutic drugs[J].Mol Immunol,2014,61(1):38. |
[21]
|
SISIRAK V,GANGULY D,LEWIS KL,et al.Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus[J].J Exp Med,2014,211(10):1969. |
[22]
|
ROWLAND SL,RIGGS JM,GILFILLAN S,et al.Early,transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model[J].J Exp Med,2011,211(10):1977. |